Have a personal or library account? Click to login
Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living Cover

Validation of a New Patient-Reported Outcome Measure of the Functional Impact of Essential Tremor on Activities of Daily Living

Open Access
|May 2024

References

  1. 1Elble R, Comella C, Fahn S, Hallett M, Jankovic J, Juncos JL, et al. Reliability of a new scale for essential tremor. Mov Disord. 2012 Oct; 27(12): 15679. DOI: 10.1002/mds.25162
  2. 2Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, et al. Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society: IPMDS Task Force on Tremor Consensus Statement. Mov Disord. 2018 Jan; 33(1): 7587. DOI: 10.1002/mds.27121
  3. 3Elble RJ. The Essential Tremor Rating Assessment Scale. Journal of Neurology. 2016; 5.
  4. 4Ondo, W, Hashem V, LeWitt PA, Pahwa R, Shih L, Tarsy D, et al. Comparison of the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor Rating Assessment Scale. Mov Disord Clin Pract. 2018; 5(1): 605. DOI: 10.1002/mdc3.12560
  5. 5Elble R, Bain P, João Forjaz M, Haubenberger D, Testa C, Goetz CG, et al. Task force report: Scales for screening and evaluating tremor: Critique and recommendations: Tremor Scales. Mov Disord. 2013 Nov; 28(13): 1793800. DOI: 10.1002/mds.25648
  6. 6U.S. FDA Center for Devices and Radiological Health, U.S. FDA Center for Biologics Evaluation and Research. Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation [Internet]. FDA; 2022 [cited 2024 Mar 10]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/principles-selecting-developing-modifying-and-adapting-patient-reported-outcome-instruments-use.
  7. 7Bain PG, Findley LJ, Atchison P, Behari M, Vidailhet M, Gresty M, et al. Assessing tremor severity. J Neurol Neurosurg Psychiatry. 1993 Aug; 56(8): 86873. DOI: 10.1136/jnnp.56.8.868
  8. 8Boateng GO, Neilands TB, Frongillo EA, Melgar-Quiñonez HR, Young SL. Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer. Front Public Health. 2018 Jun 11; 6: 149. DOI: 10.3389/fpubh.2018.00149
  9. 9Gagnier JJ, Lai J, Mokkink LB, Terwee CB. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res. 2021 Aug; 30(8): 2197218. DOI: 10.1007/s11136-021-02822-4
  10. 10Franke GH, Nentzl J, Jagla-Franke M, Prell T. Medication Adherence and Coping with Disease in Patients from a Neurological Clinic: An Observational Study. Patient Prefer Adherence. 2021; 15: 143949. DOI: 10.2147/PPA.S311946
  11. 11Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983 Jun; 67(6): 36170. DOI: 10.1111/j.1600-0447.1983.tb09716.x
  12. 12Lyons K, Troster A, Tanner C, Pahwa R. QUEST: A disease specific measure of quality of life in essential tremor patients. In: Neurology. 2005. pp. A2545. DOI: 10.1037/t68731-000
  13. 13Spinhoven Ph, Ormel J, Sloekers PPA, Kempen GIJM, Speckens AEM, Hemert AMV. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997 Mar; 27(2): 36370. DOI: 10.1017/S0033291796004382
  14. 14Djukanovic I, Carlsson J, Årestedt K. Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65–80 years old? A psychometric evaluation study. Health Qual Life Outcomes. 2017 Dec; 15(1): 193. DOI: 10.1186/s12955-017-0759-9
  15. 15Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. Journal of Psychosomatic Research. 2002 Feb 1; 52(2): 6977. DOI: 10.1016/S0022-3999(01)00296-3
  16. 16Mokkink LB, Prinsen CA, Patrick DL, Alonso J, Bouter LM, de Vet HC, et al. COSMIN Study Design checklist for Patient-reported outcome measurement instruments. In Amsterdam, The Netherlands; 2019.
  17. 17Arifin WN. A Web-based Sample Size Calculator for Reliability Studies. EIMJ. 2018 Sep 28; 10(3): 6776. DOI: 10.21315/eimj2018.10.3.8
  18. 18Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 2005 Feb; 19(1): 23140. DOI: 10.1519/00124278-200502000-00038
  19. 19Bland JM, Altman D. Statistical Methods for Assessing Agreement Between Two Methods of clinical measurement. The Lancet. 1986; 327(8476): 30710. DOI: 10.1016/S0140-6736(86)90837-8
  20. 20Papapetropoulos S, Lee MS, Versavel S, Newbold E, Jinnah HA, Pahwa R, et al. A Phase 2 Proof-of-Concept, Randomized, Placebo-Controlled Trial of CX-8998 in Essential Tremor. Movement Disorders. 2021; 36(8): 19449. DOI: 10.1002/mds.28584
  21. 21Lorenz D, Poremba C, Papengut F, Schreiber S, Deuschl G. The psychosocial burden of essential tremor in an outpatient- and a community-based cohort. Eur J Neurol. 2011 Jul; 18(7): 9729. DOI: 10.1111/j.1468-1331.2010.03295.x
  22. 22Louis ED, Barnes L, Albert SM, Cote L, Schneier FR, Pullman SL, et al. Correlates of functional disability in essential tremor. Movement Disorders. 2001 Sep; 16(5): 91420. DOI: 10.1002/mds.1184
  23. 23Louis ED, Barnes LF, Wendt KJ, Albert SM, Pullman SL, Yu Q, et al. Validity and test-retest reliability of a disability questionnaire for essential tremor. Mov Disord. 2000 May; 15(3): 51623. DOI: 10.1002/1531-8257(200005)15:3<;516::AID-MDS1015>3.0.CO;2-J
  24. 24Louis ED, Cosentino S, Huey ED. Depressive symptoms can amplify embarrassment in essential tremor. J Clin Mov Disord. 2016 Jul 15; 3: 11. DOI: 10.1186/s40734-016-0039-6
  25. 25Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results. Journal of Psychosomatic Research. 1997 Jan 1; 42(1): 1741. DOI: 10.1016/S0022-3999(96)00216-4
  26. 26Rajalingam R, Breen DP, Chen R, Fox S, Kalia LV, Munhoz RP, et al. The clinical significance of lower limb tremors. Parkinsonism & Related Disorders. 2019 Aug; 65: 16571. DOI: 10.1016/j.parkreldis.2019.06.007
  27. 27Okubadejo NU, Bankole IA, Ojo OO, Ojini FI, Danesi MA. Prevalence of essential tremor in urban Lagos, Nigeria: a door-to-door community-based study. BMC Neurology. 2012 Sep 27; 12(1): 110. DOI: 10.1186/1471-2377-12-110
  28. 28Louis ED, Barnes LF, Ford B, Pullman SL, Yu Q. Ethnic differences in essential tremor. Arch Neurol. 2000 May; 57(5): 7237. DOI: 10.1001/archneur.57.5.723
  29. 29Louis ED. Rising Problems with the Term “ET-plus”: Time for the Term Makers to Go Back to the Drawing Board. Tremor and Other Hyperkinetic Movements. 2020 Aug 13; 10(1): 28. DOI: 10.5334/tohm.555
  30. 30Tosin MHS, Goetz CG, Bispo DPCF, Ferraz HB, Leite MAA, Hall DA, et al. Parkinson’s Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan. Front Aging Neurosci. 2022; 14: 900029. DOI: 10.3389/fnagi.2022.900029
DOI: https://doi.org/10.5334/tohm.886 | Journal eISSN: 2160-8288
Language: English
Submitted on: Apr 6, 2024
Accepted on: Apr 30, 2024
Published on: May 14, 2024
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 Ludy C. Shih, Michael T. Stevenson, Steven Bellows, Alfonso Fasano, Sheng-Han Kuo, Kelly E. Lyons, Henry Moore, Holly A. Shill, Aparna Wagle Shukla, Carlos Singer, Rodger J. Elble, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.